Tundra Targeted Therapeutics
Biotechnology Research • 
United States • 1-10 Employees
Key Contact at Tundra Targeted Therapeutics
Jediah White
President and CEO
About Tundra Targeted Therapeutics
Tundra has developed a cancer treatment for patients who have not responded or are too vulnerable for current harsh therapies. We are preparing for a Phase I clinical trial in relapsed and refractory leukemias and lymphomas.
$
Tundra Targeted Therapeutics revenue & valuation
| Annual revenue | $85,555 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $273,776 |
| Total funding | $443,500 |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
C-Suite
Employees by Department
Tundra Targeted Therapeutics has 1 employees across 1 departments.
Departments
Number of employees
Costa Rica
United Arab Emirates
Italy
Canada
SpainFrequently asked questions
Tundra Targeted Therapeutics is located in US.
Tundra Targeted Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
Tundra Targeted Therapeutics has raised a total of $443,500 across 1 funding rounds. This investment has helped the company grow and expand its operations.
4.8
40,000 users
